1. Home
  2. AFYA vs NVCR Comparison

AFYA vs NVCR Comparison

Compare AFYA & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Afya Limited

AFYA

Afya Limited

HOLD

Current Price

$15.94

Market Cap

1.3B

Sector

Real Estate

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$12.68

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AFYA
NVCR
Founded
1999
2000
Country
Brazil
Switzerland
Employees
N/A
N/A
Industry
Other Consumer Services
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
AFYA
NVCR
Price
$15.94
$12.68
Analyst Decision
Hold
Buy
Analyst Count
5
6
Target Price
$17.00
$28.08
AVG Volume (30 Days)
109.9K
1.1M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
4.36%
N/A
EPS Growth
N/A
21.79
EPS
N/A
N/A
Revenue
N/A
$655,353,000.00
Revenue This Year
$10.43
$7.72
Revenue Next Year
$7.15
$6.74
P/E Ratio
$9.30
N/A
Revenue Growth
N/A
8.28
52 Week Low
$13.00
$9.82
52 Week High
$19.76
$20.05

Technical Indicators

Market Signals
Indicator
AFYA
NVCR
Relative Strength Index (RSI) 66.99 60.84
Support Level $14.02 $12.66
Resistance Level $15.88 $13.34
Average True Range (ATR) 0.46 0.54
MACD 0.06 0.29
Stochastic Oscillator 83.51 84.84

Price Performance

Historical Comparison
AFYA
NVCR

About AFYA Afya Limited

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: